People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Everlaw, Inc. | — | Other Technology | Series D+ | $306.8M | $4.6B | 2011 |
| Hillhurst Biopharmaceuticals, Inc. | — | Biotechnology | Seed | $1.8M | $13.9M | 2023 |
Jeff Friedman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff Friedman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Manu Kumar | 1 | 8 |
| Tyler Sosin | 1 | 4 |
| Steven Sinofsky | 1 | 3 |
| Mike Zappert | 1 | 3 |
| Jesse Wedler | 1 | 2 |
| Astha Malik | 1 | 2 |
| Edward Gomperts | 1 | 1 |
| Steve Berman | 1 | 1 |
| Ajeet Shankar | 1 | 1 |
| Andrew Gomperts | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.